11.24 USD
↗ 0.23 (2.14%)PRE MARKET (AS OF 08:15 AM EDT)
MiNK Therapeutics, Inc. Common Stock
INKTNASDAQ • USD
Market: OPEN
MiNK Therapeutics, Inc. Common Stock (INKT) trades at $11.24 per share. Technical and fundamental signals converge bearish — technicals rate "Sell" while fundamentals read "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (98.3%) and a bearish Death Cross on the long-term moving averages.
Technical & fundamental data as of Aug 6, 2026.
Open?$11.24
High?$11.24
Low?$11.24
Prev. Close?$11.00
Volume?102
Avg. Volume?13.0K
VWAP?$11.24
Rel. Volume?0.01x
Bid / Ask
Bid?$9.66 × 100
Ask?$13.65 × 100
Spread?$3.99
Midpoint?$11.66
Valuation & Ratios
Market Cap?54.8M
Shares Out?5.0M
Float?2.0M
Float %?39.2%
P/E Ratio?N/A
P/B Ratio?-4.32
EPS?-$2.50
Dividend?0.00%
Ex-Dividend?N/A
RelatedFTFT
News
Profile
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development and manufacturing of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. iNKT cells offer distinct therapeutic advantages as a platform for allogeneic therapy in that the cells naturally home to tissues, aid clearance of tumors and infected cells, and suppress graft-versus-host-disease. Its product candidate, agenT-797, is an off-the-shelf, allogeneic, native iNKT cell therapy. It operates its business in single segment.
Themes
Employees
15
Market Cap
54.8M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2021-10-15
Address
149 FIFTH AVENUE
NEW YORK, NY 10010
Phone: 212-994-8250
NEW YORK, NY 10010
Phone: 212-994-8250
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?68
Piotroski F-Score?0/9Weak
Altman Z-Score?-23.84Distress
Confidence?44%Low
Short InterestHigh
Short % of Float?5.10%Elevated
Short Interest?99.6K
Days to Cover?6.8
Free Float2.0M
Avg Daily Volume14.6K
Settlement Date2026-07-15
Financial Health
Current Ratio?1.38Adequate
Quick Ratio?1.38Adequate
Cash Ratio?1.31Strong
Debt/Equity?-0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?-4.32CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-3.6CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?98.3%STRONG▾
S&P97
ROA?-120.2%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$45.3M
Fundamentals ratios updated end of day